.avif)
.avif)
Sarepta Therapeutics Email Format
Biotechnology Research
・
501-1,000 employees
・
Cambridge, MA, USA
Sarepta Therapeutics is a global biotechnology company focused on engineering precision genetic medicines for rare diseases, headquartered in Cambridge, Massachusetts.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@sarepta.com
Company Overview
Industry
Biotechnology Research
Founded
1980
Headquarters
Cambridge, MA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Website
Key Executives
Douglas S. Ingram (Chief Executive Officer), Ryan H. Wong (Executive Vice President, Chief Financial Officer), Ian M. Estepan (President and Chief Operating Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Sarepta Therapeutics?
Sarepta Therapeutics uses the firstinitiallast format on sarepta.com, so Jane Smith would be jsmith@sarepta.com.
What FDA-approved therapies does Sarepta Therapeutics currently offer for Duchenne muscular dystrophy?
Sarepta Therapeutics has four FDA-approved therapies for Duchenne muscular dystrophy: Elevidys, Exondys 51, Vyondys 53, and Amondys 45. Elevidys is the first and only gene therapy approved for the disease.
How many employees does Sarepta Therapeutics have?
Sarepta Therapeutics has approximately 1,158 employees and is headquartered in Cambridge, MA. Tools like Clay can help you identify and verify the right contacts within the company for outreach or prospecting.
Across which precision genetic medicine platforms does Sarepta Therapeutics run its research programs?
Sarepta Therapeutics runs programs across three platforms: gene therapy, RNA technology including exon skipping, and gene editing. These platforms target rare neuromuscular diseases such as Duchenne, limb-girdle, facioscapulohumeral, and myotonic muscular dystrophies.
Who leads Sarepta Therapeutics as its Chief Executive Officer?
Douglas S. Ingram serves as the Chief Executive Officer of Sarepta Therapeutics. Ryan H. Wong is the Executive Vice President and Chief Financial Officer, and Ian M. Estepan serves as President and Chief Operating Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating